About Ulticare
Ulticare is a company based in Excelsior (United States) founded in 2003 was acquired by LDI in September 2014. Ulticare operates in a competitive market with competitors including Dexcom, Livongo, One Drop, Bigfoot Biomedical and Xeris Pharmaceuticals, among others.
- Headquarter Excelsior, United States
- SectorsHealthcareTechnology
- Website ulticare.com
- Social LinkedIn
- Acquired by LDI (Sep 2014)
- Investors
- Acquired byLDI
(Sep 2014)
Investors in Ulticare
Ulticare has secured backing from 1 investor. Prominent investors backing the company include Lacy Diversified.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Lacy Diversified is engaged in funding middle-market companies. | – | ldiltd.com | Indianapolis, United States |
Investor details for Ulticare
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Ulticare
2 dated milestones of Ulticare across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Ulticare is founded.
- Exit Acquired by LDI.
Competitors of Ulticare
Ulticare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, Bigfoot Biomedical and Xeris Pharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $245.2M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions | |
| bigfootbiomedical.com | 2014 | Milpitas, United States | $214.51M | 133 | Developer of a closed-loop automated insulin delivery system | |
| xerispharma.com | 2005 | Chicago, United States | $110.43M | 294 | Liquid-stable injectables are developed for peptide and protein drug delivery. | |
| mysugr.com | 2012 | Vienna, Austria | $4.8M | – | Gamified apps for diabetes management and therapy are provided. | |
| senseonics.com | 1996 | Germantown, United States | $175.46M | 132 | Implantable continuous glucose monitoring systems are provided for diabetes management. | |
| janacare.com | 2011 | Newton, United States | $26.59M | – | Mobile-based diagnostics for diabetes prevention and management are provided. | |
| telcare.com | 2008 | Bethesda, United States | $66.69M | 21 | Diabetes is managed via cellular technology and social networking. | |
| caura.com | 2016 | London, United Kingdom | $4.2M | 11 | Auto insurance and vehicle services are provided via mobile app. |
Detailed competitors of Ulticare
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Ulticare
10 companies that operate in the same segment as Ulticare (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ulticare
Ulticare was founded in 2003.
Ulticare is headquartered in Excelsior, United States. It is registered at Excelsior, Minnesota, United States.
Developer of injection devices and disposable solutions for diabetes care. The companys product line includes Pen needles, UltiGuard safe packs, UltiCare insulin safety syringes, and specialty syringes. In addition, the company offers an iPet glucose monitor (a hand-held monitoring device for a pets blood glucose).
Ulticare's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.
Ulticare has 1 investor. Key investors include Lacy Diversified.
Yes. Ulticare was acquired by LDI in September 2014.